Prevalence and predictive testing preferences for breast cancer treatment side effects
Side effects from BC treatment negatively affect quality of life and could be mitigated if their likelihood was known. Since the majority of BC patients view predictive biomarker testing favorably, future work focusing on treatment side effects is crucial to improve adherence, particularly to endocrine therapy.
Authors
- Fredrick R. Schumacher (ORCID: https://orcid.org/0000-0002-3073-7463)
- Maura K. McCall (ORCID: https://orcid.org/0000-0002-8155-6793)
- Megan E. Miller (ORCID: https://orcid.org/0000-0001-7345-1687)
- Cheryl L. Thompson (ORCID: https://orcid.org/0000-0002-6896-2367)
- Demesvar Destin
Institutions
- University Hospitals of Cleveland (US)
- University Hospitals Cleveland Medical Center (US)
- Department of Public Health (MM)
- Case Comprehensive Cancer Center
- Case Western Reserve University (US)
- Penn State Milton S. Hershey Medical Center (US)
Publication Details
- Journal
- Supportive Care in Cancer
- Published
- 2025-11-20
- DOI
- https://doi.org/10.1007/s00520-025-09976-8
- Citations
- 1
- Primary Topic
- Medication Adherence and Compliance
- Type
- article
- Field-Weighted Citation Impact
- 1.52